SCMetrix

scMetrix is a Swiss-based life sciences company specializing in high-throughput single-cell metabolomics. Spun out from ETH Zurich, the company utilizes advanced mass spectrometry technology to profile metabolites within individual cells, providing a high-resolution view of cellular heterogeneity. Their platform enables researchers to identify rare cell populations and understand metabolic changes in response to drugs or disease progression. scMetrix primarily serves the pharmaceutical industry and academic institutions, supporting drug discovery and the development of precision therapies. The company's technology is particularly impactful in fields such as oncology and immunology, where metabolic profiling can reveal critical biological insights. By bridging the gap between genomics and phenomics, scMetrix aims to accelerate the understanding of complex biological systems.